Beruflich Dokumente
Kultur Dokumente
49% increase
7.3% 7.0% 6.0% 4.9%
30.0%
1.0%
1991
2000
1990
2000
Mokdad et al. Diabetes Care. 2000; 23(9):1278-83. Mokdad et al. JAMA. 2000;286(10):1195-200. 2005. American College of Physicians. All Rights Reserved.
es d i et e t ababes Toi D
R. Heine MD
Metabolic Syndrome ?
Blood glucose
1997 PPS
DeFronzo RA. Diabetes. 1988;37:667-687. Lebovitz HE. In Joslin's Diabetes Mellitus. 1994:508-529. 2005. American College of Physicians. All Rights Reserved.
Approach to Treatment
Pharmacotherapy Tailored for the Multiple Defects of Type 2 Diabetes Phenylalanine Derivatives Meglitinides
Restore postprandial insulin patterns
Sulfonylureas
__________
_ ___ __ __ __
__________
Type 2 Diabetes
-glucosidase Inhibitors
________
Biguanide
________
14
The majority of patients will ultimately need combination therapy with oral agents and/or insulin treatment.
2005. American College of Physicians. All Rights Reserved.
Nutrition therapy decrease fat content and total calories decrease saturated fat, substitute mono/polyunsats Low glycemic index CHOs Increase dietary fiber decrease salt for hypertension healthy diet weight reduction in obese patients Exercise increase energy expenditure with moderate-intensity exercise Lifestyle changes to reduce cardiovascular risk factors (eg, smoking cessation) Training in self-management and SMBG
1997 PPS
Objectives of MNT
1. To achieve & maintain: Blood glucose in normal range or close to normal as is safely possible a lipoprotein profile that reduces the risk of vascular disease Blood pressure in normal range or close to normal as safely possible 2. To prevent, or at least slow the rate of development of the chronic complications of DM by modifying nutrient intake and lifestyle 3. To address individual nutrient needs, taking into account personal and cultural preferences and willingness to change n 4. To maintain the pleasure of eating by only limiting food choices when indicated by scientific evidence. (ADA, 2008)
19
Nutrition recommendations
CHO in dietary management:
45-65 % of total E (ADA 2006) includes CHO from fruits, veges, legumes, and low-fat milk is encourage for good health (A) Monitoring CHO whether by CHO counting, exchanges, or experience-based estimation, remains a key strategy in achieving glycemic control (A) The use of glycemic index (GI) may provide a modest additional benefit over when total CHO is considered alone (B)
Nutrition recommendations
Fat and cholesterol 25-35 % of total E (ADA 2006) Limit SAFA to 7-10 % of total calories. PUFA 10 % MUFA 10-15 % Intake of trans fat should be minimized. (E) lower dietary cholesterol to <200 mg/day (E) 2 or more servings of fish per week (with the exception of commercially fried fish filets) provide n-3 PUFA are recommended. (B)
Nutrition recommendations
Protein in diabetes management T2DM with normal renal function 1520% of E
ingested protein can increase insulin response without increasing plasma glucose concentrations. protein should not be used to treat acute or prevent nighttime hypoglycemia. (A)
23
Nutrition recommendations
High-protein diets are not recommended as a method for weight loss at this time. The long-term effects of protein intake 20% of E on DM management and its complications are unknown. Although high protein diet may produce short-term weight loss and improved glycemia, benefits and short-and long term effect to kidney function to DM px are unknown. (E)
Nutrition recommendations
Px are encouraged to implement lifestyle modifications that reduce intakes of E, and trans FA, cholesterol, and Na and to increase PA in an effort to improve glycemia, dyslipidemia, and BP. (E) Plasma glucose monitoring can be used to determine whether adjustments in foods and meals will be sufficient to achieve blood glucose goals or if medication(s) needs to be combined with MNT. (E)
Nutrition recommendations
Alcohol in diabetes management If px choose to use alcohol, daily intake should be limited to a moderate amount (E) : 1 drink/d for women 2 drinks/d for men) To reduce risk of nocturnal hypoglycemia in individuals using insulin or insulin secretagogues, alcohol should be consumed with food. (E) moderate alcohol consumption (when ingested alone) has no acute effect on glucose and insulin
sucrose
Dietary sucrose does not increase glycemia more than isocaloric amounts of starch Sucrose can be substituted for other CHO sources in the meal plan or, if added to the meal plan, adequately covered with insulin or another glucose lowering medication (A) Care should be taken to avoid excess energy intake. (ADA 2008)
Fiber
Fiber dietary management: Px are encouraged to consume a variety of fiber-containing foods. However, evidence is lacking to recommend a higher fiber intake for people with diabetes than for the population as a whole. (B) 20-30 g/day as normal population or 14g/1000 kcal
Non-nutritive sweeteners
Nonnutritive sweeteners are safe when consumed within the daily intake levels established by the FDA. (A) FDA approved 5 non-nutritive sweeteners: Acesulfame pottasium-200x sweeter than sugar Aspartame (eg. Equal, Nutrasweet)-180 x sweeter than sugar (4kcal/tsp) Neotame -6000x sweeter than sugar Saccharine (eg.Sweet'N Low) -300-400x sweeter than sugar Sucralose (eg. Splenda)-600x sweeter than sugar sugar) Safe for public including DM px and pregnant women (E=12.4 %
Non-nutritive Sweeteners
FDA has established an "acceptable daily intake" (ADI) for each sweetener. This is the maximum amount considered safe to eat each day during lifetime. Acesulfame pottasium: 15mg/kg Aspartame : 5 mg/kg Neotame: Saccharine: 5 mg/kg Sucralose: 5 mg/kg
Hypoglycemia
Ingestion of 1520 g glucose is the preferred tx for hypoglycemia, although any form of CHO that contains glucose may be used. (A) The response to tx of hypoglycemia should be apparent in 1020 min; however, plasma glucose should be tested again in 60 min, as additional treatment may be necessary. (B)
Plain biscuits & crackers Cakes & muffins Tropical fruits eg watermelon French fries, baked potatoes, mashed potatoes, tapioca